COVID-19: emergency regulations and affected legislative procedures
14th January 2021 - Regulatory alerts roundup |
Find all of CBD-Intel’s coronavirus-related regulatory alerts here, updated as they appear
CBD-Intel - complete coverage of COVID-19
Survey reveals hemp flower usage blossoming in Italy under lockdown
30th June 2020 - Business briefing |
Consumption of hemp flowers in Italy went up during the nationwide COVID-19 lockdown, despite their sale being illegal in the country, a survey has revealed
Strong online presence vital during COVID-19 crisis, CBD firm says
29th June 2020 - Business briefing |
A strong online presence has been essential to resiliency through the COVID-19 pandemic, but many larger offline retail chains that have also focused on selling through these channels may still see a recovery
Sale of white label goods affected less than anticipated during COVID crisis
29th June 2020 - Business briefing |
The loss of conferences and expos due to COVID-19 prevention measures has not affected the sale of white label goods as much as may have been anticipated, according to companies
Hemp flower now widely available in Spanish tobacconists – despite the law
17th June 2020 - Regulatory briefing |
Hemp flower has become increasingly available in Spanish tobacconists (estancos) and even on corner newsstands during the COVID-19 crisis – even thought its sale is not permitted under Spanish law
Another cannabis firm in trouble as Beleave is granted creditor protection
16th June 2020 - Business briefing |
Canadian grower Beleave has become the latest casualty of turbulent times in the cannabis industry
Is this prime time for CBD subscription models to make a mark in the market?
11th June 2020 - Business briefing |
Subscription services are a niche area of the CBD market that could benefit from the ongoing COVID-19 pandemic, providing companies with security and customers with a way to try new products without leaving home
Government aid available to European companies hit by COVID-19 measures
28th May 2020 - Business briefing |
CBD companies based in Europe have a range of possible options for government assistance to help them through the various strictures imposed due to the coronavirus pandemic
UK government help available to CBD firms hit by coronavirus measures
25th May 2020 - Business briefing |
UK companies that are struggling and in need of assistance because of due to lockdown rules in the face of the COVID-19 pandemic have several options to choose from, depending on their size and their needs
US FDA notes recall over ‘too much lead’, issues COVID-19 claim warning
22nd May 2020 - Regulatory briefing |
The US Food and Drug Administration (FDA) has published an announcement of a product recall made voluntarily by a company after tests suggested the CBD oil contained too much lead
Firm falls in line after Health Canada warning over COVID-19 claims for CBD
21st May 2020 - Regulatory briefing |
A Canadian company part-owned by singer Bif Naked has run foul of Canada’s national health authority after suggesting its CBD products can help protect users from COVID-19
US states providing tax relief measures in midst of COVID-19
8th May 2020 - Regulatory briefing |
Every state in the US is offering some sort of tax relief in response to the coronavirus pandemic, and many hemp and CBD companies may be eligible for such relief
Did COVID-19 have much of an impact on 4/20 sales?
8th May 2020 - Blog |
The answer is not quite clear. A lot of companies reported no drop or even increases in sales compared to the previous year. There could be several reasons for this. Firstly, all cannabinoid-related products are still part of a growing industry. Increases from a low base are not surprising and it is difficult to calculate […]
Figures from first socially distanced 4/20 reveal startling differences
4th May 2020 - Business briefing |
Initial reports on the results of the first ever socially distanced 4/20 are a mixed bag
Will COVID lead to delays in regulatory procedures?
1st May 2020 - Blog |
The ongoing pandemic lockdown looks to be ending in some areas with easing of measures in numerous jurisdictions. But the months lost – and continued social distancing measures which will not be entirely lifted in the near future – will have an impact on regulation going forward. However official sources are unlikely to admit and […]
The world after coronavirus ‘looks bright for investment in CBD’
27th April 2020 - Business briefing |
While the global coronavirus epidemic and consequent lockdown have caused uncertainty in the cannabis sector, investments in CBD are likely to go ahead in the coming months, some experts in the industry say
What aid is available for US CBD firms affected by coronavirus?
24th April 2020 - Blog |
CBD businesses in the US that have seen business impacted by the coronavirus pandemic and associated social measures could be eligible for a variety of state aid programmes. Extra funding for the programmes was just approved by both the US House of Representatives and Senate, with Trump expected to sign eminently. The extra funds means the […]
Podcast: CBD industry analysis during the COVID-19
24th April 2020 - Podcasts , Resources |
As the coronavirus pandemic continues, regardless of location, there is an overwhelming sense of uncertainty in the CBD industry. In this special episode, Tim Phillips – the founder and managing director of CBD-Intel — provides some analysis relating to the three main areas impacted in CBD industry: demand, supply, and regulation; however, he believes that it is too early to discuss the long-term impacts.
Government shutdown delays next step towards Mexican legalisation
23rd April 2020 - Regulatory briefing |
Further advances towards the legalisation of cannabis in Mexico have been delayed by a government shutdown due to the COVID-19 pandemic, with a new deadline for legislation set by the country’s Supreme Court
Emergency aid available for US businesses – but who will get it?
22nd April 2020 - Business briefing |
Most US hemp and CBD businesses should qualify for economic relief during the COVID-19 pandemic – but the type of assistance may vary dependent on qualification and availability of funds
‘4/20’ celebration goes online as CBD marketing adapts to lockdown
20th April 2020 - Business briefing |
CBD companies have had to adapt marketing strategies as the COVID-19 pandemic has developed. The pandemic and the associated practice of social distancing have overtaken 4/20, the biggest promotional day for cannabis
More CBD companies land in hot water with US FDA over COVID-19 claims
20th April 2020 - Regulatory briefing |
Companies that have made claims about CBD’s beneficial effects against COVID-19 are facing swift enforcement action from US regulatory authorities
How the COVID-19 crisis may impact the CBD market?
17th April 2020 - Blog |
Closures of non-essential retail will be far and away the largest factor impacting on CBD markets across the globe. It is estimated that up to 90% of offline sales in markets such as the UK happen through channels that would be deemed non-essential. And while some of that trade will transition to online channels, many […]
CBD companies are advised to use the time well as virus slows regulation
15th April 2020 - Business briefing |
CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball”
Anxiety, doubt – and some optimism – over coronavirus impact on CBD in US
14th April 2020 - Business briefing |
The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information
US state governments shut down or shut doors in face of coronavirus
1st April 2020 - Regulatory briefing |
Legislative measures are on hold in half the states of the US due to the COVID-19 emergency, with most suspending activity until at least mid-April
Industry bodies accuse ‘predatory marketers’ of spreading false claims
30th March 2020 - Business briefing |
Industry organisations have responded in anger to continued claims being made by some companies about the supposed power of cannabinoids in tackling COVID-19
Denver-to-Dallas move goes ahead despite coronavirus outbreak
25th March 2020 - Business briefing |
Also: GW suggests another possible use for Epidyolex; Lawsuit alleges hemp plants were contaminated with pesticide; Elixinol rebrands to move away from medicinal image; Kentucky hemp business goes bust
With stores everywhere being forced to close, how ‘essential’ are CBD sales?
23rd March 2020 - Business briefing |
Expected retail closures will have a significant impact on the distribution of CBD products in most major markets, according to analysis of CBD-Intel data
US authorities stamp down on false claims of anti-coronavirus properties
23rd March 2020 - Regulatory briefing |
Bogus claims that products containing CBD may have any beneficial effects in treating or warding off coronavirus risk the wrath of authorities in the US – and could ultimately damage CBD’s reputation
Company launches CBD-infused hand sanitiser: business news in brief
20th March 2020 - Business briefing |
A company has launched a hand sanitiser infused with CBD, a US wellness brand is selling what it claims is the world’s first CBD blanket, and Dog-sledding champion Lance Mackey has admitted to giving his dogs CBD, plus more
CBD events called off or put back as coronavirus tightens grip
19th March 2020 - Business briefing |
As the COVID-19 pandemic continues to affect people across the world, a swathe of CBD-related events have been called off or postponed. Here is a list of some of the major ones, with dates and details